McKesson Taps Medical-Surgical Head To Lead US Drug Operations

Date : 12/08/2010 @ 8:24AM
Source : Dow Jones News
Stock : (OCR)
Quote : 97.9  0.0 (0.00%) @ 2:05AM

McKesson Taps Medical-Surgical Head To Lead US Drug Operations

Mckesson (NYSE:MCK)
Historical Stock Chart

5 Years : From Jul 2012 to Jul 2017

Click Here for more Mckesson Charts.

McKesson Corp. (MCK) tapped Brian S. Tyler to lead its huge U.S. pharmaceutical business as the unit's current president, John Figueroa, prepares to leave for the top spot at nursing-home pharmacy services provider Omnicare Inc. (OCR).

The transition comes as McKesson, the largest U.S. pharmaceuticals distributor by revenue, has seen slight revenue and margin growth of late. In October it reported its fiscal second-quarter profit rose 8.6% as revenue fell short of analysts' views. Its pharmaceutical-distribution business, which makes up the vast majority of its top line, saw revenue increase 1.3%.

Tyler, a 13-year veteran of the company, has been leading McKesson's much smaller medical-surgical business. His successor has yet to be named.

Figueroa had overseen the Omnicare account for roughly a dozen years while at McKesson. He takes the new role as Omnicare has struggled with a third-quarter loss, a slashed 2010 earnings forecast and the abrupt departure of longtime Chief Executive Joel Gemunder.

McKesson shares closed Tuesday at $66.85 while Omnicare finished at $23.01. Neither was active premarket.

-By Matt Jarzemsky, Dow Jones Newswires; 212-416-2240; matthew.jarzemsky@dowjones.com

 
 


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.